Benitec Biopharma Inc. (BNTC) DCF Valuation

Benitec Biopharma Inc. (BNTC) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Benitec Biopharma Inc. (BNTC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Make informed investment choices with the Benitec Biopharma Inc. (BNTC) DCF Calculator! Explore genuine Benitec financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Benitec Biopharma Inc. (BNTC).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .1 .0 .0 .0 .1 .2 .2 .2 .3 .4
Revenue Growth, % 0 -39.18 23.73 2.74 188 21.82 21.82 21.82 21.82 21.82
EBITDA -4.9 -8.4 -11.1 -11.6 -14.0 -.2 -.2 -.2 -.3 -.4
EBITDA, % -8151.55 -23044.07 -24457.53 -24933.33 -10412.04 -100 -100 -100 -100 -100
Depreciation .2 .3 .2 .2 .0 .1 .2 .2 .2 .3
Depreciation, % 385.57 718.64 536.99 508 0 80 80 80 80 80
EBIT -5.1 -8.7 -11.3 -11.8 -14.0 -.2 -.2 -.2 -.3 -.4
EBIT, % -8537.11 -23762.71 -24994.52 -25441.33 -10412.04 -100 -100 -100 -100 -100
Total Cash 6.1 12.3 2.5 1.5 31.6 .2 .2 .2 .3 .4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .1
Account Receivables, % 60.82 42.37 4.11 0 106.02
Inventories .6 .0 .0 .0 .0 .0 .0 .1 .1 .1
Inventories, % 977.32 0 0.00246575 17.33 0 23.47 23.47 23.47 23.47 23.47
Accounts Payable .2 .2 .3 .7 .8 .2 .2 .2 .3 .4
Accounts Payable, % 290.72 464.41 578.08 1520 625.46 100 100 100 100 100
Capital Expenditure -.1 -.1 .0 .0 -.1 -.1 -.1 -.1 -.2 -.2
Capital Expenditure, % -97.94 -374.58 -17.81 -1.33 -82.87 -59.99 -59.99 -59.99 -59.99 -59.99
Tax Rate, % 2.77 2.77 2.77 2.77 2.77 2.77 2.77 2.77 2.77 2.77
EBITAT -5.2 -8.6 -11.6 -11.8 -13.6 -.2 -.2 -.2 -.3 -.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.4 -7.9 -11.2 -11.2 -13.7 -.8 -.1 -.2 -.2 -.3
WACC, % 9.72 9.71 9.72 9.72 9.68 9.71 9.71 9.71 9.71 9.71
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -3
Present Terminal Value -2
Enterprise Value -3
Net Debt -31
Equity Value 28
Diluted Shares Outstanding, MM 4
Equity Value Per Share 6.88

What You Will Get

  • Real BNTC Financial Data: Pre-filled with Benitec Biopharma's historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Benitec Biopharma’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Data: Benitec Biopharma’s historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Observe Benitec Biopharma’s intrinsic value recalibrating instantly.
  • Intuitive Visual Outputs: Dashboard graphs illustrate valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • Download: Get the pre-built Excel file containing Benitec Biopharma Inc.'s (BNTC) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose This Calculator for Benitec Biopharma Inc. (BNTC)?

  • Accurate Data: Utilize real Benitec Biopharma financials for dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations streamline your process, saving you time.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Designed with an intuitive interface and clear instructions to accommodate users of all levels.

Who Should Use This Product?

  • Investors: Assess the fair value of Benitec Biopharma Inc. (BNTC) to inform investment strategies.
  • CFOs: Utilize a comprehensive DCF model for accurate financial reporting and analysis.
  • Consultants: Easily modify the template for client valuation reports specific to Benitec Biopharma Inc. (BNTC).
  • Entrepreneurs: Understand financial modeling techniques applied by leading biotech firms.
  • Educators: Employ this resource as a teaching aid to illustrate valuation approaches in biotech.

What the Template Contains

  • Pre-Filled DCF Model: Benitec Biopharma Inc.'s (BNTC) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to Benitec Biopharma Inc. (BNTC).
  • Financial Ratios: Assess Benitec Biopharma Inc.'s (BNTC) profitability, leverage, and efficiency metrics.
  • Editable Inputs: Modify assumptions like growth rates, margins, and CAPEX to suit your analysis for Benitec Biopharma Inc. (BNTC).
  • Financial Statements: Access annual and quarterly reports for comprehensive evaluation of Benitec Biopharma Inc. (BNTC).
  • Interactive Dashboard: Effortlessly visualize key valuation metrics and outcomes for Benitec Biopharma Inc. (BNTC).

No products were found matching.